Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg
Dosage Form : Rota cap
Packaging Type : in a bottle with carton
Packaging : 30 Capsules
Price : ₹1/-
Glycopryl F is a specialized inhalation medication designed for the effective management of chronic obstructive pulmonary disease (COPD). Each Rota Cap contains a precise combination of Glycopyrronium (25 mcg) and Formoterol Fumarate (6 mcg), which work synergistically to provide long-lasting relief from respiratory symptoms.
Glycopyrronium is an anticholinergic agent that helps to relax and open the airways by blocking the action of acetylcholine, a neurotransmitter that can cause bronchoconstriction. This action leads to improved airflow and reduced breathlessness. Formoterol Fumarate, a long-acting beta-agonist (LABA), complements this effect by stimulating beta-2 adrenergic receptors in the lungs, resulting in further bronchodilation. Together, these components help to alleviate symptoms such as wheezing, coughing, and shortness of breath, enhancing the quality of life for individuals with COPD.
Common side effects may include dry mouth, headache, dizziness, and palpitations. Some patients may experience throat irritation or cough. It is important to monitor for any unusual or severe reactions.
Glycopryl F is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults.
Glycopryl F should be used only as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms persist or worsen.
Store Glycopryl F in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children to ensure safety.
Composition : Glycopyrrolate (25mcg) Respule
Composition : Glycopyrrolate IP 50mcg Rota Capsule
Composition : Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Rota Capsule
Composition : Tiotropium (18mcg) Rotacaps
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (200mcg) + Formoterol (6mcg) Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation